Neurogene Stock Performance
as on October 1, 2026 at 5:08 am IST
Day's Low
Day's High
$27.40$28.61
0.69%
Downside
3.70%
Upside
52 Week's Low
52 Week's High
$15.93$43.6642.26%
Downside
58.25%
Upside
Neurogene share price movements today
- Previous Close
- $28.39
- Open
- $28.41
- Volume
- 133.5K
- Market Cap
- $569.9M
- Day's Low - High
- $27.40 - $28.61
- 52 Week Low - High
- $15.93 - $43.66
Neurogene Historical Returns
- 1 Month Return
- -22.39 %
- 3 Month Return
- -9.73 %
- 1 Year Return
- + 63.82 %
- 3 Year Return
- 0 %
- 5 Year Return
- 0 %
Neurogene Stock Fundamentals & Key Indicators
Check Neurogene market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$569.9M
EPS (TTM)
-5.51
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-5.17
Industry PE ratio
-8.70
PEG Ratio
0.29
EBITDA
-106.3M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-45.11%
Neurogene vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Neurogene with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| StrongBuy | $569.9M | NA | -5.17 | 0.00% | 0.00% | |
| StrongBuy | $43.2B | 643.29% | -22.77 | 0.00% | 0.00% | |
| Neutral | $78.8B | -47.13% | -24.72 | -12.57% | 0.00% | |
| StrongBuy | $133.4B | 189.75% | 30.38 | 86.04% | 0.00% | |
| Buy | $81.1B | 24.01% | 17.96 | 84.86% | 0.49% |
Stock Returns calculator for Neurogene Stock including INR - Dollar returns
The Neurogene stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Neurogene investment value today
Current value as on today
₹1,71,728
Returns
₹71,728
(+71.73%)
Returns from Neurogene Stock
₹59,204 (+59.2%)
Dollar Impact
₹12,524 (+12.52%)
Analyst Recommendation on Neurogene Stock
Based on 7 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 7 analysts, 100% of analysts recommend a 'BUY' rating for Neurogene. Average target price of $80.43
Neurogene Share Price Target
Get share price movements and forecasts by analysts on Neurogene.
What analysts predicted
65.7%UPSIDE
Target Price
$80.43
Current Price
$27.59
Analyzed by
7 Analysts
High
$166
Target
$80.43
Low
$46
Neurogene target price $80.43, a slight upside of 65.7% compared to current price of $27.59. According to 7 analysts rating.
Indian Investors' Interest in Neurogene Stock
Search interest for Neurogene Stock has decreased by -10% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Neurogene Quarterly Profit & Loss
All numbers in Millions USD
Neurogene Annual Profit & Loss
All numbers in Millions USD
Neurogene Quarterly Cash Flow
All numbers in Millions USD
Neurogene Annual Cash Flow
All numbers in Millions USD
Insights on Neurogene
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 3 Years
In the last 3 years, NGNE has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Price Rise
In the last 1 year, NGNE stock has moved up by 63.8%
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 687.7% return, outperforming this stock by 623.9%
About Neurogene
| Organisation | Neurogene |
| Headquarters | 535 W 24th Street, New York City, NY, 10011, US |
| Industry | Biotechnology |
| CEO | Rachel L. McMinn |
Key Management of Neurogene
Name | Title |
|---|---|
Dr. Rachel L. McMinn Ph.D. | Founder, Executive Chair & CEO |
Dr. Julie Jordan M.D. | Chief Medical Officer |
Ms. Lina Li | Executive Director of Investor Relations |
Dr. Andrew E. Mulberg CPI, FAAP, M.D. | Senior VP of Regulatory Affairs, Quality Assurance & Quality Control |
Mr. Arvind Sreedharan | Senior Vice President of Business Operations |
Ms. Christina Shafer | Chief Commercial Officer |
Ms. Christine Mikail Cvijic J.D. | President, CFO & Director |
Dr. Stuart Cobb Ph.D. | Chief Scientific Officer |
Ms. Donna M. Cochener-Metcalfe J.D., L.L.M. | Senior VP, General Counsel & Corporate Secretary |
Mr. Ricardo Jimenez | Senior Vice President of Technical Operations |
FAQs
What is Neurogene share price today?
Neurogene share price today is $27.59 as on . Neurogene share today touched a day high of $28.61 and a low of $27.40.
What is the 52 week high and 52 week low for Neurogene share?
Neurogene share touched a 52 week high of $43.66 on and a 52 week low of $15.93 on . Neurogene stock price today i.e. is trending at $27.59,which is 36.81% down from its 52 week high and 73.20% up from its 52 week low.
What is Neurogene's market capitalisation today?
Neurogene market capitalisation is $0.00T as on .
How to invest in Neurogene Stock (NGNE) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Neurogene on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Neurogene Stock (NGNE) from India?
Indian investors can start investing in Neurogene (NGNE) shares with as little as ₹95.83000183105469 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.30 in Neurogene stock (as per the Rupee-Dollar exchange rate as on ).
Based on Neurogene share’s latest price of $27.59 as on September 30, 2026 at 11:38 pm IST, you will get 0.3625 shares of Neurogene. Learn more about
fractional shares .